Terms: = Cervical cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Clinical Outcome
5 results:
1. Automated localization and segmentation of cervical lymph nodes on contrast-enhanced CT using a 3D foveal fully convolutional neural network.
Rinneburger M; Carolus H; Iuga AI; Weisthoff M; Lennartz S; Hokamp NG; Caldeira L; Shahzad R; Maintz D; Laqua FC; Baeßler B; Klinder T; Persigehl T
Eur Radiol Exp; 2023 Jul; 7(1):45. PubMed ID: 37505296
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
Gu KW; Kim CK; Choi CH; Yoon YC; Park W
Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
[TBL] [Abstract] [Full Text] [Related]
3. Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.
Holm R; de Putte GV; Suo Z; Lie AK; Kristensen GB
Int J Med Sci; 2008 Jun; 5(3):121-6. PubMed ID: 18566674
[TBL] [Abstract] [Full Text] [Related]
4. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract] [Full Text] [Related]
5. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
[TBL] [Abstract] [Full Text] [Related]
